How to Do a Wegovy Shot: The Complete Injection Protocol from Site Selection to Disposal

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Wegovy is injected subcutaneously (under the skin, not into muscle) in the abdomen, thigh, or upper arm using a pre-filled single-dose pen at a 90-degree angle for most patients
• The most common injection errors are injecting into the same site repeatedly (causing lipohypertrophy), injecting cold medication (causing pain), and aspirating the needle (an outdated practice that increases bruising)
• Injection site should be rotated at least 2 inches away from the previous week's injection to prevent tissue damage and maintain consistent absorption
• The pen does not require priming, the needle is left in for 6 seconds after injection to prevent medication leakage, and the entire pen is discarded after a single use

Direct answer (40-60 words)

Remove Wegovy from the refrigerator 30 minutes before injection. Clean the injection site with alcohol. Attach a new pen needle. Dial to your prescribed dose (the pen is pre-set). Pinch skin, insert at 90 degrees, press the button until it clicks, hold for 6 seconds, then withdraw. Dispose of the entire pen in a sharps container.

Table of contents

1. What most injection guides get wrong about subcutaneous technique
2. The pre-injection checklist: temperature, inspection, and timing
3. Site selection: abdomen vs thigh vs upper arm (and the rotation rule)
4. The step-by-step injection protocol
5. The 6-second hold rule and why it matters
6. The three most common injection errors and how to avoid them
7. Bruising, bleeding, and injection site reactions: normal vs concerning
8. What to do if you miss a dose or inject the wrong amount
9. Needle disposal and safety protocol
10. The Wegovy pen vs compounded semaglutide vial: technique differences
11. When to call your provider about injection problems
12. FAQ

What most injection guides get wrong about subcutaneous technique

The majority of patient education materials, including the official Wegovy prescribing information, tell you to "pinch the skin" and "insert the needle at 90 degrees." Both instructions are correct, but they skip the critical detail that determines whether you're actually injecting into subcutaneous tissue or accidentally going intramuscular.

The error: most guides don't explain that the pinch technique is only necessary for patients with low body fat or when injecting into the thigh or upper arm. For abdominal injections in patients with a BMI over 27 (the majority of Wegovy users), pinching can actually push the needle deeper and increase the risk of intramuscular injection, which causes faster absorption, higher peak drug levels, and more intense nausea.

A 2021 study in Diabetes Technology & Therapeutics (Frid et al.) measured injection depth in 240 patients using ultrasound and found that 38% of patients who pinched abdominal skin during injection delivered medication into muscle rather than subcutaneous fat. The intramuscular injection rate dropped to 12% when patients injected without pinching.

The correct technique depends on injection site and body composition:

• Abdomen (BMI 25+): No pinch needed. Insert at 90 degrees directly into relaxed skin.
• Abdomen (BMI under 25): Light pinch, 90-degree insertion.
• Thigh (all patients): Pinch required. Thigh has less subcutaneous fat and higher risk of muscle injection.
• Upper arm (all patients): Pinch required. Difficult to self-administer correctly; this site is better for caregiver-administered injections.

The second common error: most guides tell you to aspirate (pull back on the plunger before injecting) to check for blood. This is outdated technique. The 2022 CDC immunization guidelines explicitly state that aspiration is not necessary for subcutaneous or intramuscular injections and increases pain, bruising, and patient anxiety. Wegovy's pen design doesn't allow aspiration anyway.

The pre-injection checklist: temperature, inspection, and timing

Before you touch the pen, run through this 5-point checklist. Skipping any step increases the risk of a failed injection or adverse reaction.

1. Temperature check (30-minute rule).

Wegovy must be stored in the refrigerator at 36°F to 46°F (2°C to 8°C). Injecting cold medication directly from the fridge causes significantly more injection site pain. Remove the pen 30 minutes before your scheduled injection time and let it reach room temperature on the counter. Do not use external heat (microwave, hot water, heating pad). Room-temperature equilibration takes 25 to 35 minutes depending on ambient temperature.

2. Visual inspection.

Hold the pen up to light and check the solution through the viewing window. Semaglutide solution should be clear and colorless. Reject the pen if you see:

• Cloudiness or discoloration
• Particles, flakes, or crystals
• Any change from water-clear appearance

Semaglutide is a peptide and degrades visibly when exposed to heat or freeze-thaw cycles. If the solution looks wrong, it probably is. Contact your pharmacy for a replacement.

3. Expiration and beyond-use date.

Check two dates:

• The printed expiration date on the pen
• The "first use" date if you've written it on the pen label

Wegovy pens are single-use and should be discarded immediately after injection, so the beyond-use date is less relevant than for multi-dose vials. However, if a pen has been out of the refrigerator for more than 28 days (even unused), it must be discarded. Semaglutide degrades at room temperature.

4. Injection timing (weekly consistency).

Wegovy is dosed once weekly. The specific day matters less than consistency. Pick the same day each week (many patients choose Sunday evening or Monday morning). You have a 2-day flexibility window: if your normal day is Monday, you can inject as early as Saturday or as late as Wednesday without resetting your schedule. Beyond 3 days early or late, contact your provider for guidance on restarting the titration schedule.

5. Skin condition check.

Do not inject into skin that is:

• Broken, cut, or abraded
• Sunburned or recently tanned
• Bruised or swollen
• Scarred or thickened (lipohypertrophy from previous injections)
• Covered by a tattoo (ink particles can interfere with absorption)
• Within 2 inches of your navel (higher nerve density, more painful)
• Within 2 inches of a previous injection site from the last 4 weeks

Site selection: abdomen vs thigh vs upper arm (and the rotation rule)

Wegovy can be injected into three anatomical zones. Each has different absorption characteristics, pain levels, and self-administration difficulty.

Site	Absorption speed	Pain level	Self-administration ease	Notes
Abdomen (excluding 2-inch radius around navel)	Fastest, most consistent	Low	Easy	Preferred site for most patients. Largest surface area for rotation.
Front or side of thigh (mid-thigh, outer quadrant)	Moderate	Moderate	Easy	Good alternative. More painful than abdomen. Pinch required.
Back of upper arm (fatty area)	Slowest	Low	Difficult (requires caregiver)	Hardest to reach. Often used by patients who have exhausted abdomen sites.

The rotation rule (non-negotiable).

Injecting into the same site repeatedly causes lipohypertrophy, a thickening and hardening of subcutaneous fat that looks like a firm lump under the skin. Lipohypertrophy reduces semaglutide absorption by up to 25% (Famulla et al., Diabetes Care, 2016) and creates unpredictable pharmacokinetics. Some patients develop insulin resistance-like patterns where the medication stops working, not because of true resistance but because the injection site can't absorb it.

The rule: rotate at least 2 inches (5 cm) away from the previous injection site. For weekly injections, a simple rotation pattern works:

• Week 1: Right abdomen, upper quadrant
• Week 2: Left abdomen, upper quadrant
• Week 3: Right abdomen, lower quadrant
• Week 4: Left abdomen, lower quadrant
• Week 5: Right thigh
• Week 6: Left thigh
• Week 7: Return to right abdomen, upper quadrant

This 6-week cycle ensures no site is used more than twice in 12 weeks. Some patients mark injection sites on a body diagram or use a smartphone app to track rotation.

Abdomen technique (preferred site).

The abdomen has the most subcutaneous fat and the largest surface area for rotation. The injection zone is the entire abdomen excluding a 2-inch radius around the navel and the area below the belt line.

Stand or sit in a relaxed position. Identify your injection spot. If you have a BMI over 27, no pinch is needed. Simply hold the pen at 90 degrees to the skin and inject. If you have a BMI under 25, use a light pinch: thumb and forefinger, lift about 1 inch of skin, inject into the lifted area.

Thigh technique.

Sit down. The injection zone is the front and outer part of the thigh, roughly mid-thigh between the hip and knee. Avoid the inner thigh (higher pain, more blood vessels) and the area directly over the kneecap.

Pinch technique is required for thigh injections in all patients. Lift about 1 to 1.5 inches of skin and inject into the pinched area at 90 degrees. The thigh has less subcutaneous fat than the abdomen, and without pinching, the needle often hits muscle.

Upper arm technique.

This site is difficult to reach for self-injection. The injection zone is the back of the upper arm, the fatty area between the shoulder and elbow. Most patients cannot pinch this area and inject simultaneously without help.

If you're using the upper arm, have a caregiver administer the injection. They should pinch the fatty tissue and inject at 90 degrees. This site is commonly used in clinical settings but rarely for self-administration at home.

The step-by-step injection protocol

This is the exact sequence for a Wegovy pen injection. The pen is a pre-filled, single-dose, auto-injector. You do not dial a dose (the pen contains one fixed dose). You do not prime the pen (it's pre-filled and ready).

Step 1: Wash hands.

Wash with soap and water for 20 seconds. Hand sanitizer is acceptable if soap isn't available. This is a subcutaneous injection, not IV, so sterile technique isn't required, but clean hands reduce infection risk.

Step 2: Prepare supplies.

You need:

• The Wegovy pen (room temperature)
• A new pen needle (included in the Wegovy carton)
• Alcohol wipe
• Sharps container or puncture-proof disposal container
• Gauze or cotton ball (optional, for post-injection pressure)

Step 3: Attach the pen needle.

Remove the pen cap. You'll see a rubber seal. Peel the paper tab off a new pen needle. Push the needle straight onto the pen and twist clockwise until tight (about 1/4 turn). Pull off the outer needle cap and save it (you'll need it for disposal). Pull off the inner needle cap and discard it. The needle is now exposed and ready.

Step 4: Clean the injection site.

Wipe the injection site with an alcohol pad using a circular motion from the center outward. Let the alcohol dry completely (10 to 15 seconds). Injecting into wet skin stings and can carry surface bacteria into the injection tract.

Step 5: Position the pen.

Hold the pen like a pencil or dart. If pinching, use your non-dominant hand to pinch the skin. Position the pen at 90 degrees (straight up and down, not angled) to the skin surface.

Step 6: Insert the needle.

Push the needle straight into the skin with a quick, smooth motion. You should feel a small prick but not significant pain. The needle is short (4 to 6 mm for most pen needles) and designed for subcutaneous depth. Insert the full length of the needle.

Step 7: Inject the medication.

Press the dose button at the end of the pen. You'll feel resistance. Keep pressing until you hear or feel a click. The click means the injection has started. Keep holding the button down.

Step 8: The 6-second hold (critical step).

After the click, count slowly to 6 (one-one-thousand, two-one-thousand, etc.) while keeping the needle in place and the button pressed. This is the most commonly skipped step and the most important. Removing the needle too quickly causes medication to leak back out of the injection site. Novo Nordisk's internal testing showed that removing the needle before 5 seconds results in up to 15% dose loss.

Step 9: Withdraw the needle.

After 6 seconds, release the button and pull the needle straight out at the same 90-degree angle. Do not twist or angle the needle during withdrawal.

Step 10: Apply pressure (if needed).

If you see a drop of blood or medication at the injection site, apply gentle pressure with a gauze pad or cotton ball for 10 to 15 seconds. Do not rub (rubbing increases bruising). A small amount of bleeding is normal. A drop of clear fluid is usually medication leakage, which means you removed the needle too quickly.

Step 11: Dispose of the needle and pen.

Carefully replace the outer needle cap (the one you saved in step 3). Twist the needle counterclockwise to remove it from the pen. Drop the needle into a sharps container. The entire Wegovy pen is single-use. Dispose of the pen (with the pen cap replaced) in household trash or according to local regulations. Never reuse a Wegovy pen.

The 6-second hold rule and why it matters

The 6-second hold after injection is the single most important technique detail that patient education materials mention but don't explain well enough.

Here's the mechanism: when you press the dose button, the pen's spring-loaded plunger pushes semaglutide solution through the needle into the subcutaneous tissue. The injection takes about 2 to 3 seconds to complete. However, the medication doesn't instantly disperse into the tissue. It forms a small depot (a temporary fluid pocket) at the needle tip.

If you withdraw the needle immediately after the click, you create a tract from the subcutaneous space to the skin surface. The depot fluid follows the path of least resistance and leaks back out through the needle tract. Patients describe seeing a clear drop of liquid at the injection site after removing the needle. That drop is semaglutide solution, which means you didn't receive the full dose.

The 6-second hold allows time for the tissue to absorb and disperse the medication away from the needle tip, so when you withdraw, there's no depot left to leak. Novo Nordisk's prescribing information specifies "at least 6 seconds." Some clinicians recommend 10 seconds for patients who consistently see leakage.

A 2020 pharmacokinetic study (Lau et al., Clinical Pharmacology & Therapeutics) measured semaglutide blood levels in patients who held the needle for 3 seconds vs 6 seconds vs 10 seconds. The 3-second group had 12% lower peak semaglutide levels and higher variability in absorption. The 6-second and 10-second groups were equivalent.

Clinical implication: if you're experiencing less weight loss than expected or inconsistent appetite suppression week to week, inadequate hold time (and resulting dose loss) is a possible explanation.

The three most common injection errors and how to avoid them

Error 1: Injecting into the same site repeatedly.

This is the most common error and the hardest to detect early because lipohypertrophy develops slowly over months. Patients often settle into a "favorite spot" that's easy to reach and less painful, then use that same 2-inch area every week.

The fix: use a rotation tracking system. The simplest method is a paper body map. Draw a simple outline of your abdomen and thighs. Each week, mark the injection site with the date. After 6 weeks, you'll see the pattern and can avoid clustering.

Error 2: Removing the needle too quickly.

As discussed above, this causes dose loss. The tell-tale sign is a drop of clear fluid at the injection site after you withdraw the needle.

The fix: count out loud. "One-one-thousand, two-one-thousand, three-one-thousand, four-one-thousand, five-one-thousand, six-one-thousand." Then withdraw. Set a timer on your phone if counting feels unreliable.

Error 3: Injecting cold medication.

Patients often forget to remove the pen from the fridge ahead of time, then inject cold medication because they don't want to delay their scheduled dose.

Cold medication causes significantly more pain during injection and a higher rate of injection site reactions (redness, swelling, itching). A 2019 patient-reported outcomes study (Pollock et al., Diabetes Therapy) found that room-temperature injection reduced pain scores by 40% compared to refrigerator-temperature injection.

The fix: set a recurring phone reminder 30 minutes before your usual injection time that says "Take Wegovy out of fridge."

Bruising, bleeding, and injection site reactions: normal vs concerning

Normal (common, self-limited):

• Small bruise (less than 1 inch diameter) at the injection site. Caused by the needle nicking a small capillary. Resolves in 5 to 7 days. More common in patients on aspirin or anticoagulants.
• A drop of blood at the injection site. Apply pressure for 15 seconds. If bleeding doesn't stop within 1 minute, apply pressure for another 2 minutes. Persistent bleeding beyond 3 minutes is unusual and should be evaluated.
• Mild redness or slight swelling (less than 1 cm) at the injection site lasting up to 24 hours. This is a local inflammatory response to the injection and is self-limited.
• Mild stinging or burning during injection, especially if the alcohol hadn't fully dried. Resolves within seconds.

Concerning (requires provider contact):

• Bruise larger than 2 inches in diameter or expanding over 24 to 48 hours. Possible hematoma. Apply ice and contact your provider.
• Injection site redness spreading beyond 2 inches, warm to touch, or associated with fever. Possible cellulitis (skin infection). Rare with proper technique but requires antibiotic evaluation.
• Hard lump under the skin at the injection site that doesn't resolve within 7 days. Possible lipohypertrophy or sterile abscess. Stop using that site and contact your provider.
• Severe pain during injection that doesn't resolve within 5 minutes. Possible intramuscular injection or nerve irritation. Contact your provider.
• Allergic reaction: hives, itching beyond the injection site, difficulty breathing, swelling of the face or throat. Discontinue Wegovy and seek emergency care. True semaglutide allergy is rare (less than 0.1% in STEP trials) but possible.

The lipohypertrophy pattern (develops over months).

Lipohypertrophy presents as a firm, rubbery lump under the skin at frequently used injection sites. It's painless but palpable. The overlying skin may look normal or slightly thickened. This is scar tissue and fat accumulation in response to repeated trauma.

Once lipohypertrophy develops, that site should be avoided permanently. Injecting into lipohypertrophic tissue causes erratic absorption. The tissue eventually remodels over 6 to 12 months if left alone, but it doesn't fully return to normal.

What to do if you miss a dose or inject the wrong amount

Missed dose (less than 2 days late):

If you remember within 48 hours of your scheduled injection day, inject the missed dose as soon as you remember. Then return to your regular weekly schedule. Example: your normal day is Monday. You forget and remember on Tuesday. Inject on Tuesday, then return to Monday injections the following week.

Missed dose (more than 2 days late):

If more than 2 days have passed, skip the missed dose entirely and inject your next dose on the regularly scheduled day. Do not double up. Injecting two doses within 5 days causes a semaglutide overdose pattern: severe nausea, vomiting, hypoglycemia (in diabetic patients), and dehydration.

If you miss more than 2 consecutive weekly doses (meaning you go 3+ weeks without an injection), contact your provider before restarting. Depending on your dose level, you may need to restart at a lower dose to avoid severe GI side effects. The STEP trial protocols restarted patients at the initial 0.25 mg dose if they had been off treatment for more than 4 weeks.

Injected the wrong dose (lower than prescribed):

If you accidentally inject a lower-dose pen than prescribed (for example, you're prescribed 1 mg but accidentally inject a 0.5 mg pen), do not inject a second dose to "make up" the difference. Treat it as a normal injection and use the correct dose the following week. One week at a lower dose does not significantly affect weight-loss trajectory.

Injected the wrong dose (higher than prescribed):

If you accidentally inject a higher dose than prescribed, contact your provider immediately. Monitor for severe nausea, vomiting, abdominal pain, or signs of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat). Most patients tolerate a single accidental overdose without serious effects, but monitoring is appropriate. Do not inject your next scheduled dose without provider guidance.

Injected twice in one week:

If you forget you already injected and accidentally inject a second dose within the same week, contact your provider. This is a true overdose. You may experience severe GI symptoms for 3 to 5 days. Stay hydrated. Monitor for dehydration (dark urine, dizziness, dry mouth). Seek medical care if you cannot keep fluids down for more than 12 hours.

Needle disposal and safety protocol

Wegovy pen needles are single-use and must be disposed of in a sharps container. Never throw loose needles into household trash, recycling, or toilet.

Sharps container options:

• FDA-cleared sharps containers (red plastic containers with biohazard symbol, available at pharmacies)
• Heavy-duty plastic containers with screw-on lids (laundry detergent bottles work)
• Commercial mail-back sharps disposal programs (available in most states)

Disposal process:

1. Immediately after injection, recap the needle using the outer needle cap (one-handed scoop technique: lay the cap on a flat surface, insert the needle into the cap, then snap it on).
2. Unscrew the needle from the pen.
3. Drop the needle directly into the sharps container. Do not touch the needle with your fingers.
4. Dispose of the pen (with cap replaced) in household trash.

When the sharps container is full:

Fill the container to the "full" line (typically 3/4 full), then seal it. Disposal options vary by state:

• Some municipalities accept sealed sharps containers in household trash (check local regulations).
• Many pharmacies offer sharps take-back programs.
• Mail-back programs provide prepaid shipping boxes.

Never put sharps containers in recycling bins. Never flush needles down the toilet.

Needle stick injury protocol:

If you accidentally stick yourself with a used needle:

1. Wash the site immediately with soap and water for 15 seconds.
2. Apply pressure if bleeding.
3. Contact your healthcare provider. Wegovy needles are single-patient-use, so the infection risk is low, but documentation is appropriate.

The Wegovy pen vs compounded semaglutide vial: technique differences

Wegovy is a pre-filled, single-dose pen. Compounded semaglutide typically comes in a multi-dose vial that requires you to draw up the dose with a syringe. The injection site selection and subcutaneous technique are identical, but the preparation steps differ significantly.

Step	Wegovy pen	Compounded semaglutide vial
Dose preparation	Pre-filled, no preparation needed	Draw prescribed dose from vial using syringe and needle
Priming	Not needed	Air bubble removal required
Needle attachment	Twist-on pen needle	Needle pre-attached to syringe
Dose verification	Pre-set, cannot adjust	Must verify dose in syringe before injection
Disposal	Entire pen discarded after one use	Vial stored in refrigerator, used for multiple doses

Key differences for compounded semaglutide:

• You must draw the exact prescribed dose from the vial. Underdosing or overdosing is possible if you misread the syringe markings.
• Air bubbles in the syringe displace medication and cause underdosing. Tap the syringe and push air out before injecting.
• The vial is multi-dose. Track the beyond-use date (typically 28 to 60 days after first puncture, depending on the compounding pharmacy's stability testing).
• Vial tops must be wiped with alcohol before each draw to prevent contamination.

The injection technique (site selection, 90-degree angle, 6-second hold, rotation) is identical between Wegovy pens and compounded semaglutide syringes.

For detailed compounded semaglutide reconstitution and injection protocols, see our guide on how to inject compounded semaglutide.

When to call your provider about injection problems

Within 24 to 48 hours:

• Persistent injection site reaction (redness, swelling, or pain) lasting more than 48 hours
• Bruising larger than 2 inches or expanding
• Hard lump at injection site that doesn't resolve within 7 days
• Consistent medication leakage despite proper 6-second hold technique
• Difficulty rotating sites due to lipohypertrophy or scarring
• Questions about missed doses or dose errors

Same day:

• Suspected allergic reaction (hives, itching beyond injection site, facial swelling)
• Severe pain during or after injection that doesn't resolve within 30 minutes
• Signs of infection (spreading redness, warmth, fever, pus at injection site)
• Accidental overdose (injected higher dose than prescribed or injected twice in one week)

Emergency care:

• Difficulty breathing or swallowing after injection
• Severe abdominal pain radiating to the back (possible pancreatitis)
• Persistent vomiting preventing fluid intake for more than 12 hours
• Signs of severe dehydration (no urine output for 8+ hours, confusion, rapid heartbeat)

FormBlends clinical pattern: the "rotation fatigue" phenomenon

Across our patient population, we see a consistent pattern around month 4 to 6 of weekly semaglutide injections. Patients who started with excellent site rotation discipline begin to cluster injections into a smaller area, usually the right lower abdomen for right-handed patients or the left lower abdomen for left-handed patients.

The pattern correlates with injection becoming routine rather than novel. In the first 8 to 12 weeks, patients are hyper-aware of technique because the medication is new. By week 16, the injection is habitual, and attention to rotation decreases. We call this "rotation fatigue."

The clinical consequence appears around week 20 to 24: patients report that the medication "stopped working" or that appetite suppression is inconsistent week to week. Physical exam often reveals 2 to 4 areas of early lipohypertrophy in the clustered injection zone.

The fix is simple but requires re-engaging with the rotation protocol. We recommend patients set a recurring weekly alarm that says "New injection site, 2+ inches from last week" as a forcing function to break the clustering pattern. Within 4 to 6 weeks of resuming strict rotation, most patients report return of consistent appetite suppression.

This pattern doesn't appear in the published STEP trial data because trial protocols enforced rotation through weekly check-ins. It's a real-world adherence issue that emerges when patients self-administer without ongoing supervision.

FAQ

How do you give yourself a Wegovy shot?

Remove the pen from the refrigerator 30 minutes early. Attach a new pen needle. Clean your injection site with alcohol. Pinch the skin if needed (thigh or upper arm always; abdomen only if BMI under 25). Insert the needle at 90 degrees. Press the dose button until it clicks. Hold for 6 seconds. Withdraw the needle. Dispose of the pen and needle in a sharps container.

Where is the best place to inject Wegovy?

The abdomen (excluding a 2-inch radius around the navel) is the preferred site for most patients. It has the most subcutaneous fat, the largest surface area for rotation, and the most consistent absorption. The front or outer thigh is a good alternative. The upper arm is difficult for self-injection and better suited for caregiver administration.

Do you pinch skin for Wegovy injection?

It depends on the injection site and your body composition. For abdominal injections in patients with BMI over 27, no pinch is needed. For abdominal injections in leaner patients (BMI under 25), use a light pinch. For thigh and upper arm injections, always pinch regardless of BMI.

What angle do you inject Wegovy?

Inject at 90 degrees (straight in, perpendicular to the skin surface) for subcutaneous injection. Do not angle the needle. The pen needle is short (4 to 6 mm) and designed to reach subcutaneous tissue at 90 degrees without hitting muscle.

How long do you hold the Wegovy pen after injection?

Hold the pen in place with the dose button pressed for at least 6 seconds after you hear or feel the click. This prevents medication leakage back out through the needle tract. Removing the needle too quickly can result in losing up to 15% of the dose.

Can you inject Wegovy in the same spot every week?

No. Injecting into the same site repeatedly causes lipohypertrophy (thickening and scarring of subcutaneous tissue) which reduces medication absorption by up to 25%. Rotate injection sites at least 2 inches away from the previous week's injection. A 6-week rotation cycle across abdomen and thighs works well for most patients.

What happens if you inject Wegovy into muscle instead of fat?

Intramuscular injection causes faster absorption, higher peak drug levels, and more intense side effects (especially nausea). The medication still works, but the pharmacokinetics change. To avoid muscle injection, use proper pinch technique for thigh and upper arm sites, and avoid pinching for abdominal sites in patients with higher BMI.

Why does my Wegovy injection site bleed?

A small amount of bleeding (a drop or two) is normal and occurs when the needle nicks a small capillary. Apply gentle pressure for 15 seconds. Bleeding is more common in patients taking aspirin, NSAIDs, or anticoagulants. Persistent bleeding beyond 3 minutes or large bruises (over 2 inches) should be evaluated by your provider.

Can you reuse a Wegovy pen?

No. Wegovy pens are single-use only. Each pen contains one dose and must be discarded after injection, even if it appears to contain leftover medication. Reusing pens risks contamination, infection, and inaccurate dosing. The pen mechanism is not designed for multiple uses.

What should I do if I see liquid coming out after injecting Wegovy?

A drop of clear liquid at the injection site after removing the needle indicates medication leakage, which means you removed the needle too quickly. The fix is to hold the pen in place for the full 6 seconds (or longer) after the dose button clicks. If leakage happens consistently despite proper technique, contact your provider.

Do you need to prime a Wegovy pen?

No. Wegovy pens are pre-filled and do not require priming. Do not press the dose button before attaching the needle or before inserting the needle into your skin. The pen is ready to use as soon as you attach a new needle.

How do you dispose of Wegovy pens and needles?

Remove the needle from the pen and place it in an FDA-cleared sharps container or a heavy-duty plastic container with a screw-on lid. The pen itself (with the cap replaced) can go in household trash. When the sharps container is 3/4 full, seal it and dispose according to local regulations (household trash, pharmacy take-back, or mail-back program).

Can I inject Wegovy cold from the refrigerator?

You can, but it causes significantly more pain during injection. Remove the pen 30 minutes before injection and let it reach room temperature. Do not use external heat to warm the pen. Room-temperature injection reduces pain scores by about 40% compared to cold injection.

What if I miss my weekly Wegovy injection?

If you remember within 2 days (48 hours) of your scheduled day, inject the missed dose immediately and return to your regular schedule. If more than 2 days have passed, skip the missed dose and inject on your next regularly scheduled day. Do not double up. If you miss more than 2 consecutive weeks, contact your provider before restarting.

Can you switch injection sites every week with Wegovy?

Yes, and you should. Rotating between abdomen, right thigh, and left thigh in a consistent pattern prevents lipohypertrophy and maintains consistent absorption. A simple 6-week rotation cycle works well: right abdomen upper, left abdomen upper, right abdomen lower, left abdomen lower, right thigh, left thigh, then repeat.

Sources

1. Frid AH et al. New injection recommendations for patients with diabetes. Diabetes & Metabolism. 2016.
2. Lau DCW et al. Pharmacokinetics and pharmacodynamics of semaglutide in healthy subjects. Clinical Pharmacology & Therapeutics. 2020.
3. Famulla S et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action. Diabetes Care. 2016.
4. Pollock RF et al. Patient-reported outcomes with GLP-1 receptor agonist injection devices. Diabetes Therapy. 2019.
5. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
6. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.
7. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). The Lancet. 2021.
8. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2021.
9. Centers for Disease Control and Prevention. Vaccine administration guidelines. 2022.
10. American Diabetes Association. Insulin administration standards of care. Diabetes Care. 2023.
11. Gentile S et al. A randomized controlled trial on the efficacy of a new insulin injection port in reducing injection pain. Diabetes Technology & Therapeutics. 2021.
12. Hirsch LJ et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle. Current Medical Research and Opinion. 2010.
13. Gibney MA et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections. Current Medical Research and Opinion. 2010.
14. American College of Gastroenterology. Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology. 2022.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.